AMY THOMPSON: Open Payments
NPI 1336100064 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 45 payments from 13 companies in 2025. Trend: 2023 $624 · 2024 $1,050 · 2025 $2,606
Travel & lodging: $1,351Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,845 |
| Novo Nordisk Inc | 2 | $149 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $143 |
| ABIOMED | 1 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| PFIZER INC. | 4 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $28 |
Products named: NEFFY, Ozempic, JARDIANCE, ELIQUIS, LEQVIO, AMVUTTRA, FARXIGA, Attruby.
Industry payments across NC — which companies pay providers there.
